Dio Tree vs Trobix Bio
Dio Tree vs Trobix Bio, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Dio Tree is on 44/100 and Trobix Bio on 49/100.
Where each one leads
Dio Tree
- agent readiness: 50/100 against 21/100
- funding raised: $15.0M against $3.0M
Trobix Bio
- our overall score: 49/100 against 44/100
At a glance
| Measure | Dio Tree | Trobix Bio |
|---|---|---|
| What it is | Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3. | Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology. |
| Category | Life Sciences, Oncology, Biotech, Drug Discovery | Life Sciences, Microbiome, Oncology, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Drug discovery | Software |
| Founded | 2022 | 2019 |
| Headquarters | Cambridge, United States | San Diego, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Dio Tree | Trobix Bio |
|---|---|---|
| Employees | Not published | 13 |
| Headcount growthLast 12 months | Not published | +115.3% |
| Total funding | $15.0M | $3.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | Not published | 564 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Dio Tree | Trobix Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 49/100 |
| Traction | 36/100 | 44/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 4/100 | 42/100 |
| Quality | 50/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 5/100 |
Dio Tree vs Trobix Bio: common questions
Which is better, Dio Tree or Trobix Bio?
On our 0-100 score Trobix Bio rates higher (49/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Dio Tree and Trobix Bio compare on the numbers?
Dio Tree leads on agent readiness (50/100 against 21/100), funding raised ($15.0M against $3.0M). Trobix Bio leads on our overall score (49/100 against 44/100).
Read the full Dio Tree review and pricing or the Trobix Bio review and pricing. You can also browse other Dio Tree alternatives we track.